港股恆指飆漲3.5%,地產、醫藥、半導體全面爆發
6月1日早盤,港股市場迎來難得集體大反彈行情,在開市不久後恆指高開高走,盤中一度大漲超過800點,最高報23806.32點,漲幅超3.5%,並伴隨明顯放量成交,國指成分股亦大漲接近3%,最高報9847.48點。
有分析認為,在週末的特朗普中國記者會中,針對中國方面未提及任何經濟制裁和貿易行動,此前被市場預期的取消香港本土關税地位更沒有提起,這被市場解讀為雷聲大雨點小,悲觀的預期再次明顯轉為積極,從而刺激今日港股市場大漲。
盤面上,半導體、應用軟件、生物醫藥、地產、消費電子、乳製品等板塊全面飆升,其中不乏漲幅超1成的明星股。

地產板塊方面,內地及香港本地地產商均集團大漲,其中萬科企業、中海外發展、中國恆大、華潤置地、龍湖集團、碧桂園、恆基地產、融創中國等均漲超4%。同時,地產商的大漲也帶動了物業板塊的大漲。建業新生活、新城悦服務、時代鄰里均漲超5%、奧園健康、雅生活服務、碧桂園服務、寶龍商業等漲超3%。

消息上,昨日,克而瑞地產研究發佈今年前五月房地產企業銷售TOP100排行榜。榜單顯示,5月百強房企實現全口徑銷售金額10915.4億元,環比增長21.3%,同比增速顯著提升至12.2%。其中,67家房企單月業績同比提升;近半重點城市成交同比轉正。
前五個月累計,百強房企全口徑銷售額降幅較前幾月持續收窄,同比下降7.9%,自3月以來繼續收窄。
5月百強房企中77家房企單月環比上升,67家房企銷售同比增長。碧桂園因五一期間促銷及線上直播,5月份全口徑銷售金額為798億元,創年內新高,同比增長13.2%。世茂、金地、金茂、招商、龍光、佳兆業、中樑等房企5月銷售業績同比及環比均實現較明顯增長。
半導體板塊,中芯國際、ASM太平洋、華虹半導體等漲幅亦在5%左右。
生物醫藥板塊,海王英特龍、中國生物製藥大漲超8%,康臣藥業、三生製藥、康龍化成、國藥控股等漲幅在5%以上。

券商板塊方面,中信建投漲超5%,港交所、中信證券、華泰證券、海通證券、招生證券等漲超3%。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.